Neutropenia in patients under treatment with clozapine and COVID-19 infection
Introduction Clozapine is among the most effective antipsychotics used for treatment resistant schizophrenia. Adverse reactions to clozapine include neutropenia. Case series report that clozapine-treated patients with COVID-19 have no documented neutropenia. Objectives We sought to investigate t...
| الحاوية / القاعدة: | European Psychiatry |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Cambridge University Press
2021-04-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.cambridge.org/core/product/identifier/S092493382101796X/type/journal_article |
